UK Regulator Recalls Clopidogrel Products Over Under-Dosing Concerns

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a recall for all strengths of Xeal Pharma's Clopidogrel Oral Suspension and Solution. This action was taken because the antiplatelet medication products were found to contain less than the stated amount of clopidogrel. The recall is a patient safety measure addressing a manufacturing defect.